SMS Clinical Research

02/20/2026

Ulcerative Colitis affects more than digestion. It can impact energy levels, daily routines, and overall quality of life.

Clinical research plays an important role in advancing treatment options and understanding UC more deeply. Participating in a research study may provide access to study-related care while helping researchers work toward better solutions for the future.
✨ Your experience matters.
✨ Your participation can make a difference.

👉 Take the first step and learn more about Ulcerative Colitis research opportunities today. 📞(972) 216-5100

02/18/2026

Looking for clinical trials in Mesquite, TX? 🩺✨

At SMS Clinical Research, we are committed to advancing medicine while providing compassionate, patient focused care. Led by Dr. Salma Saiger, our team works hard to bring innovative research opportunities to our community.

Participating in a clinical trial could give you access to cutting edge treatments while helping shape the future of healthcare. Your involvement truly makes a difference. 💙

02/18/2026

We were honored to be part of the Community Outreach & Educational Event at the Mesquite Arts Center! 💙

At SMS Clinical Research, we believe education empowers healthier communities. Connecting with local families, sharing valuable health information, and answering questions about clinical trials is what we’re passionate about.

Thank you to everyone who stopped by our table and took the time to learn more about advancing medicine together. Your participation makes a difference, not just today, but for the future of healthcare.

02/16/2026

SMS Clinical Research is conducting a clinical study to learn more about how investigational influenza vaccines work in adults.
Participants may receive:
• Study-related medical care
• Health monitoring during the study
• Compensation for time and participation

This study is for research purposes and does not replace regular medical care.
👉 Contact us today to learn more: (972) 216-5100

02/15/2026

Patrick Soon-Shiong has introduced Anktiva, an immunotherapy designed to activate the body’s natural killer (NK) cells — a key part of the immune system that detects and destroys abnormal or cancerous cells. Rather than directly attacking tumors like chemotherapy or radiation, this approach aims to strengthen the body’s own immune defenses.

Anktiva (nogapendekin alfa inbakicept) is an IL-15 superagonist that helps expand and activate NK cells and certain T cells. It has been studied in combination with other therapies, particularly in bladder cancer. In 2024, the U.S. FDA approved Anktiva in combination with BCG for certain patients with non–muscle invasive bladder cancer that is unresponsive to BCG alone.

Clinical data suggest that enhancing NK cell activity may help improve tumor response while potentially reducing some of the systemic side effects seen with traditional treatments. However, like all cancer therapies, effectiveness can vary by cancer type and patient condition, and ongoing trials are evaluating broader applications and long-term outcomes.

Experts describe treatments like Anktiva as part of a larger shift toward precision immunotherapy — focusing on empowering the immune system rather than solely destroying cancer cells through cytotoxic methods.

While continued research is needed to assess durability of response and safety across more cancer types, NK cell–based therapies represent a growing and promising frontier in oncology.

02/14/2026

We often think of chocolates or flowers, but the real gift is being present for life’s moments, big and small.

At SMS Clinical Research, we believe investing in your health today helps you stay there for the milestones, the laughter, and the everyday moments that matter most. Because a healthier future means more time with the people you love.

💬 Tell us in the comments: How do you like to spend a healthy day with your Valentine?

02/11/2026

Living with Crohn’s or ulcerative colitis? You may qualify for a clinical trial in Mesquite, TX. This study is exploring new ways to manage these conditions through cutting-edge research.

✨ What you can expect:
✔ Study-related care at no cost
✔ Access to investigational treatment
✔ Reimbursement for time and travel

You may qualify if:
(1) You are between (18–75) years old
(2) Have a confirmed diagnosis of Crohn’s or UC
(3) Meet study criteria at screening

📍 Location: SMS Clinical Research, Mesquite TX
📞 Call (972) 216-5100
🌐 https://smsclinicalresearch.com/

02/09/2026

Chronic coughing and shortness of breath shouldn't be your "normal." At SMS Clinical Research, we are seeking adults with moderate to severe COPD for a landmark Phase III Clinical Trial. We are testing an innovative subcutaneous injection aimed at reducing those frequent, scary flare-ups that lead to hospital stays. If your current inhalers aren't enough, it’s time to see if this new research path is right for you.

02/06/2026

❤️

02/06/2026

Stop waiting for relief that never comes.
SMS Clinical Research is actively enrolling participants for a Phase III Crohn’s Disease clinical study designed for adults who continue to experience moderate to severe symptoms despite current treatment.

This study evaluates an investigational therapy that may help reduce inflammation and improve quality of life. All study-related care, evaluations, and monitoring are provided at no cost.

You may be eligible if you:
• Are an adult diagnosed with Crohn’s disease
• Have ongoing symptoms despite current medications
• Are interested in research-based treatment options
✨ Take control of your care.
✨ Explore a new treatment option.
✨ Help shape the future of Crohn’s disease research.

📲 Apply today to see if you qualify.
Your first step toward remission could start here.
(972) 216-5100

02/06/2026

❤️❤️ Stop by on Valentines and see us at the Winter GLOW Fest & learn all about our current & "enrolling soon" studies! ❤️❤️

We are less than two weeks away from Fest! 2026.

Check out our line-up. We will also have on the scene ❤️🤤🍪

Learn more here: https://www.mesquiteartscenter.org/events/2026/2nd-annual-winter-glow-fest

02/04/2026

This Black History Month, we honor the Black researchers and scientists whose groundbreaking work has transformed healthcare and saved countless lives. Innovators like Dr. Charles Drew, whose research revolutionized blood storage and transfusions, Dr. Kizzmekia Corbett, whose work was central to modern vaccine development, and Dr. Ernest Everett Just, a pioneer in cell biology, laid the foundation for medical advances we rely on today. Their dedication, resilience, and pursuit of discovery continue to inspire progress, equity, and excellence in research and medicine.